Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 362 entries
Sorted by: Best Match Show Resources per page
Mental retardation.

Science (New York, N.Y.)

Weir MW.
PMID: 6028925
Science. 1967 Aug 04;157(3788):576-7. doi: 10.1126/science.157.3788.576.

No abstract available.

Cite
Weir MW. Mental retardation. Science. 1967;157(3788):576-7doi: 10.1126/science.157.3788.576.
Weir, M. W. (1967). Mental retardation. Science (New York, N.Y.), 157(3788), 576-7. https://doi.org/10.1126/science.157.3788.576
Weir, M W. "Mental retardation." Science (New York, N.Y.) vol. 157,3788 (1967): 576-7. doi: https://doi.org/10.1126/science.157.3788.576
Weir MW. Mental retardation. Science. 1967 Aug 04;157(3788):576-7. doi: 10.1126/science.157.3788.576. PMID: 6028925.
Copy Download .nbib Format: NLM
Novel carbon nanotube (CNT)-based ultrasensitive sensors for trace mercury(II) detection in water: A review.

The Science of the total environment

Pokhrel LR, Ettore N, Jacobs ZL, Zarr A, Weir MH, Scheuerman PR, Kanel SR, Dubey B.
PMID: 27539821
Sci Total Environ. 2017 Jan 01;574:1379-1388. doi: 10.1016/j.scitotenv.2016.08.055. Epub 2016 Aug 16.

Infamous for "Mad hatter syndrome" and "Minamata disease", mercury (Hg) is ranked high on the Agency for Toxic Substances and Disease Registry's priority list of hazardous substances for its potent neurologic, renal, and developmental toxicities. Most typical exposures are...

Cite
Pokhrel LR, Ettore N, Jacobs ZL, et al. Novel carbon nanotube (CNT)-based ultrasensitive sensors for trace mercury(II) detection in water: A review. Sci Total Environ. 2016;574:1379-1388doi: 10.1016/j.scitotenv.2016.08.055.
Pokhrel, L. R., Ettore, N., Jacobs, Z. L., Zarr, A., Weir, M. H., Scheuerman, P. R., Kanel, S. R., & Dubey, B. (2017). Novel carbon nanotube (CNT)-based ultrasensitive sensors for trace mercury(II) detection in water: A review. The Science of the total environment, 5741379-1388. https://doi.org/10.1016/j.scitotenv.2016.08.055
Pokhrel, Lok R, et al. "Novel carbon nanotube (CNT)-based ultrasensitive sensors for trace mercury(II) detection in water: A review." The Science of the total environment vol. 574 (2017): 1379-1388. doi: https://doi.org/10.1016/j.scitotenv.2016.08.055
Pokhrel LR, Ettore N, Jacobs ZL, Zarr A, Weir MH, Scheuerman PR, Kanel SR, Dubey B. Novel carbon nanotube (CNT)-based ultrasensitive sensors for trace mercury(II) detection in water: A review. Sci Total Environ. 2017 Jan 01;574:1379-1388. doi: 10.1016/j.scitotenv.2016.08.055. Epub 2016 Aug 16. PMID: 27539821.
Copy Download .nbib Format: NLM
Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort.

Kidney international reports

Afshinnia F, Rajendiran TM, Karnovsky A, Soni T, Wang X, Xie D, Yang W, Shafi T, Weir MR, He J, Brecklin CS, Rhee EP, Schelling JR, Ojo A, Feldman H, Michailidis G, Pennathur S.
PMID: 28451650
Kidney Int Rep. 2016 Nov;1(4):256-268. doi: 10.1016/j.ekir.2016.08.007. Epub 2016 Aug 18.

INTRODUCTION: Human studies report conflicting results on the predictive power of serum lipids on progression of chronic kidney disease (CKD). We aimed to systematically identify the lipids that predict progression to end-stage kidney disease.METHODS: From the Chronic Renal Insufficiency...

Cite
Afshinnia F, Rajendiran TM, Karnovsky A, et al. Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort. Kidney Int Rep. 2016;1(4):256-268doi: 10.1016/j.ekir.2016.08.007.
Afshinnia, F., Rajendiran, T. M., Karnovsky, A., Soni, T., Wang, X., Xie, D., Yang, W., Shafi, T., Weir, M. R., He, J., Brecklin, C. S., Rhee, E. P., Schelling, J. R., Ojo, A., Feldman, H., Michailidis, G., & Pennathur, S. (2016). Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort. Kidney international reports, 1(4), 256-268. https://doi.org/10.1016/j.ekir.2016.08.007
Afshinnia, Farsad, et al. "Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort." Kidney international reports vol. 1,4 (2016): 256-268. doi: https://doi.org/10.1016/j.ekir.2016.08.007
Afshinnia F, Rajendiran TM, Karnovsky A, Soni T, Wang X, Xie D, Yang W, Shafi T, Weir MR, He J, Brecklin CS, Rhee EP, Schelling JR, Ojo A, Feldman H, Michailidis G, Pennathur S. Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort. Kidney Int Rep. 2016 Nov;1(4):256-268. doi: 10.1016/j.ekir.2016.08.007. Epub 2016 Aug 18. PMID: 28451650; PMCID: PMC5402253.
Copy Download .nbib Format: NLM
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia.

Kidney international

Bushinsky DA, Williams GH, Pitt B, Weir MR, Freeman MW, Garza D, Stasiv Y, Li E, Berman L, Bakris GL.
PMID: 26376130
Kidney Int. 2015 Dec;88(6):1427-1433. doi: 10.1038/ki.2015.270. Epub 2015 Sep 16.

Patients with chronic kidney disease (CKD) have a high risk of hyperkalemia, which increases mortality and can lead to renin-angiotensin-aldosterone system inhibitor (RAASi) dose reduction or discontinuation. Patiromer, a nonabsorbed potassium binder, has been shown to normalize serum potassium...

Cite
Bushinsky DA, Williams GH, Pitt B, et al. Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. Kidney Int. 2015;88(6):1427-1433doi: 10.1038/ki.2015.270.
Bushinsky, D. A., Williams, G. H., Pitt, B., Weir, M. R., Freeman, M. W., Garza, D., Stasiv, Y., Li, E., Berman, L., & Bakris, G. L. (2015). Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. Kidney international, 88(6), 1427-1433. https://doi.org/10.1038/ki.2015.270
Bushinsky, David A, et al. "Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia." Kidney international vol. 88,6 (2015): 1427-1433. doi: https://doi.org/10.1038/ki.2015.270
Bushinsky DA, Williams GH, Pitt B, Weir MR, Freeman MW, Garza D, Stasiv Y, Li E, Berman L, Bakris GL. Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. Kidney Int. 2015 Dec;88(6):1427-1433. doi: 10.1038/ki.2015.270. Epub 2015 Sep 16. PMID: 26376130; PMCID: PMC4678168.
Copy Download .nbib Format: NLM
Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study.

Canadian journal of kidney health and disease

Gandhi S, McArthur E, Reiss JP, Mamdani MM, Hackam DG, Weir MA, Garg AX.
PMID: 27069639
Can J Kidney Health Dis. 2016 Apr 11;3:21. doi: 10.1186/s40697-016-0111-z. eCollection 2016.

BACKGROUND: A number of case reports have suggested a possible association between atypical antipsychotic medications and hyponatremia. Currently, there are no reliable estimates of hyponatremia risk from atypical antipsychotic drugs.OBJECTIVE: The objective of this study was to examine the...

Cite
Gandhi S, McArthur E, Reiss JP, et al. Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study. Can J Kidney Health Dis. 2016;3:21doi: 10.1186/s40697-016-0111-z.
Gandhi, S., McArthur, E., Reiss, J. P., Mamdani, M. M., Hackam, D. G., Weir, M. A., & Garg, A. X. (2016). Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study. Canadian journal of kidney health and disease, 321. https://doi.org/10.1186/s40697-016-0111-z
Gandhi, Sonja, et al. "Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study." Canadian journal of kidney health and disease vol. 3 (2016): 21. doi: https://doi.org/10.1186/s40697-016-0111-z
Gandhi S, McArthur E, Reiss JP, Mamdani MM, Hackam DG, Weir MA, Garg AX. Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study. Can J Kidney Health Dis. 2016 Apr 11;3:21. doi: 10.1186/s40697-016-0111-z. eCollection 2016. PMID: 27069639; PMCID: PMC4827184.
Copy Download .nbib Format: NLM
Is there an optimal strategy for pretransplant cardiovascular screening?.

Transplantation

Weir MR.
PMID: 25769067
Transplantation. 2015 Apr;99(4):656-7. doi: 10.1097/TP.0000000000000612.

No abstract available.

Cite
Weir MR. Is there an optimal strategy for pretransplant cardiovascular screening?. Transplantation. 2015;99(4):656-7doi: 10.1097/TP.0000000000000612.
Weir, M. R. (2015). Is there an optimal strategy for pretransplant cardiovascular screening?. Transplantation, 99(4), 656-7. https://doi.org/10.1097/TP.0000000000000612
Weir, Matthew R. "Is there an optimal strategy for pretransplant cardiovascular screening?." Transplantation vol. 99,4 (2015): 656-7. doi: https://doi.org/10.1097/TP.0000000000000612
Weir MR. Is there an optimal strategy for pretransplant cardiovascular screening?. Transplantation. 2015 Apr;99(4):656-7. doi: 10.1097/TP.0000000000000612. PMID: 25769067.
Copy Download .nbib Format: NLM
The complex challenge of chronic obstructive pulmonary disease.

The Lancet. Respiratory medicine

Duffy S, Weir M, Criner GJ.
PMID: 26679019
Lancet Respir Med. 2015 Dec;3(12):917-9. doi: 10.1016/S2213-2600(15)00480-4.

No abstract available.

Cite
Duffy S, Weir M, Criner GJ. The complex challenge of chronic obstructive pulmonary disease. Lancet Respir Med. 2015;3(12):917-9doi: 10.1016/S2213-2600(15)00480-4.
Duffy, S., Weir, M., & Criner, G. J. (2015). The complex challenge of chronic obstructive pulmonary disease. The Lancet. Respiratory medicine, 3(12), 917-9. https://doi.org/10.1016/S2213-2600(15)00480-4
Duffy, Sean, et al. "The complex challenge of chronic obstructive pulmonary disease." The Lancet. Respiratory medicine vol. 3,12 (2015): 917-9. doi: https://doi.org/10.1016/S2213-2600(15)00480-4
Duffy S, Weir M, Criner GJ. The complex challenge of chronic obstructive pulmonary disease. Lancet Respir Med. 2015 Dec;3(12):917-9. doi: 10.1016/S2213-2600(15)00480-4. PMID: 26679019.
Copy Download .nbib Format: NLM
Antihypertensive combination therapy.

Drugs of today (Barcelona, Spain : 1998)

Weir MR.
PMID: 15094858
Drugs Today (Barc). 1998 Jan;34(1):5-9. doi: 10.1358/dot.1998.34.1.485192.

The rationale behind employing combination antihypertensive therapy stems from growing evidence that there is a greater need for more aggressive control of systemic arterial pressure to levels below what we have traditionally accepted (140/90 mmHg), and that we have...

Cite
Weir MR. Antihypertensive combination therapy. Drugs Today (Barc). 1998;34(1):5-9doi: 10.1358/dot.1998.34.1.485192.
Weir, M. R. (1998). Antihypertensive combination therapy. Drugs of today (Barcelona, Spain : 1998), 34(1), 5-9. https://doi.org/10.1358/dot.1998.34.1.485192
Weir, M R. "Antihypertensive combination therapy." Drugs of today (Barcelona, Spain : 1998) vol. 34,1 (1998): 5-9. doi: https://doi.org/10.1358/dot.1998.34.1.485192
Weir MR. Antihypertensive combination therapy. Drugs Today (Barc). 1998 Jan;34(1):5-9. doi: 10.1358/dot.1998.34.1.485192. PMID: 15094858.
Copy Download .nbib Format: NLM
Direct renin inhibitors: where will they fit in for antihypertensive treatment?.

Current hypertension reports

Weir MR.
PMID: 18177585
Curr Hypertens Rep. 2007 Nov;9(5):389-91. doi: 10.1007/s11906-007-0071-x.

No abstract available.

Cite
Weir MR. Direct renin inhibitors: where will they fit in for antihypertensive treatment?. Curr Hypertens Rep. 2007;9(5):389-91doi: 10.1007/s11906-007-0071-x.
Weir, M. R. (2007). Direct renin inhibitors: where will they fit in for antihypertensive treatment?. Current hypertension reports, 9(5), 389-91. https://doi.org/10.1007/s11906-007-0071-x
Weir, Matthew R. "Direct renin inhibitors: where will they fit in for antihypertensive treatment?." Current hypertension reports vol. 9,5 (2007): 389-91. doi: https://doi.org/10.1007/s11906-007-0071-x
Weir MR. Direct renin inhibitors: where will they fit in for antihypertensive treatment?. Curr Hypertens Rep. 2007 Nov;9(5):389-91. doi: 10.1007/s11906-007-0071-x. PMID: 18177585.
Copy Download .nbib Format: NLM
Radiation damage, at high temperatures.

Science (New York, N.Y.)

Weir JR.
PMID: 17813028
Science. 1967 Jun 30;156(3783):1689-95. doi: 10.1126/science.156.3783.1689.

The successful development of nuclear power reactors that are economically competitive with other sources of energy has led us to believe that more economical reactors will be developed. But, in developing the next generation of reactors, a new set...

Cite
Weir JR. Radiation damage, at high temperatures. Science. 1967;156(3783):1689-95doi: 10.1126/science.156.3783.1689.
Weir, J. R. (1967). Radiation damage, at high temperatures. Science (New York, N.Y.), 156(3783), 1689-95. https://doi.org/10.1126/science.156.3783.1689
Weir, J R. "Radiation damage, at high temperatures." Science (New York, N.Y.) vol. 156,3783 (1967): 1689-95. doi: https://doi.org/10.1126/science.156.3783.1689
Weir JR. Radiation damage, at high temperatures. Science. 1967 Jun 30;156(3783):1689-95. doi: 10.1126/science.156.3783.1689. PMID: 17813028.
Copy Download .nbib Format: NLM
Bioactive Polymeric ACP Composites Utilizing Ethyl-α-hydroxymethylacrylate.

Papers presented at the ... meeting. American Chemical Society. Division of Polymer Chemistry

Antonucci JM, Fowler BO, Stansbury JW, Weir MD, Skrtic D.
PMID: 18941543
Polymer Prepr. 2008;49(1):820-821.

No abstract available.

Cite
Antonucci JM, Fowler BO, Stansbury JW, et al. Bioactive Polymeric ACP Composites Utilizing Ethyl-α-hydroxymethylacrylate. Polymer Prepr. 2008;49(1):820-821
Antonucci, J. M., Fowler, B. O., Stansbury, J. W., Weir, M. D., & Skrtic, D. (2008). Bioactive Polymeric ACP Composites Utilizing Ethyl-α-hydroxymethylacrylate. Papers presented at the ... meeting. American Chemical Society. Division of Polymer Chemistry, 49(1), 820-821.
Antonucci, J M, et al. "Bioactive Polymeric ACP Composites Utilizing Ethyl-α-hydroxymethylacrylate." Papers presented at the ... meeting. American Chemical Society. Division of Polymer Chemistry vol. 49,1 (2008): 820-821.
Antonucci JM, Fowler BO, Stansbury JW, Weir MD, Skrtic D. Bioactive Polymeric ACP Composites Utilizing Ethyl-α-hydroxymethylacrylate. Polymer Prepr. 2008;49(1):820-821. PMID: 18941543; PMCID: PMC2568899.
Copy Download .nbib Format: NLM
Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994.

Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association

Weir R.
PMID: 17057430
Pediatr Phys Ther. 2003;15(1):42-3. doi: 10.1097/01.PEP.0000055981.78074.5E.

No abstract available.

Cite
Weir R. Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994. Pediatr Phys Ther. 2003;15(1):42-3doi: 10.1097/01.PEP.0000055981.78074.5E.
Weir, R. (2003). Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994. Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association, 15(1), 42-3. https://doi.org/10.1097/01.PEP.0000055981.78074.5E
Weir, Rodney. "Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994." Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association vol. 15,1 (2003): 42-3. doi: https://doi.org/10.1097/01.PEP.0000055981.78074.5E
Weir R. Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994. Pediatr Phys Ther. 2003;15(1):42-3. doi: 10.1097/01.PEP.0000055981.78074.5E. PMID: 17057430.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 362 entries